President Trump's Executive Order Aims to Lower Drug Prices by Aligning Small Molecule Drug Policy with Biologics
President Trump's latest executive order modifies the Medicare Drug Price Negotiation Program, aligning the treatment of small molecule drugs with biologics and aiming to reduce drug prices.